Clinical spectrum of X-linked hyper-IgM syndrome

被引:471
|
作者
Levy, J
EspanolBoren, T
Thomas, C
Fischer, A
Tovo, P
Bordigoni, P
Resnick, I
Fasth, A
Baer, M
Gomez, L
Sanders, EAM
Tabone, MD
Plantaz, D
Etzioni, A
Monafo, V
Abinun, M
Hammarstrom, L
Abrahamsen, T
Jones, A
Finn, A
Klemola, T
DeVries, E
Sanal, O
Peitsch, MC
Notarangelo, LD
机构
[1] SOROKA HOSP, BEER SHEVA, ISRAEL
[2] HOSP GEN VALLE HEBRON, BARCELONA, SPAIN
[3] HOP NECKER ENFANTS MALAD, PARIS, FRANCE
[4] UNIV TURIN, TURIN, ITALY
[5] UNIV NANCY, NANCY, FRANCE
[6] INST PEDIT HEMATOL, MOSCOW, RUSSIA
[7] UNIV GOTHENBURG, GOTHENBURG, SWEDEN
[8] UNIV TAMPERE, FIN-33101 TAMPERE, FINLAND
[9] INST IMMUNOL, MOSCOW, RUSSIA
[10] WILHELMINA GASTHUIS, UTRECHT, NETHERLANDS
[11] HOP TROUSSEAU, F-75571 PARIS, FRANCE
[12] UNIV GRENOBLE, GRENOBLE, FRANCE
[13] RAMBAM MED CTR, HAIFA, ISRAEL
[14] UNIV PAVIA, I-27100 PAVIA, ITALY
[15] NEWCASTLE GEN HOSP, NEWCASTLE UPON TYNE NE4 6BE, TYNE & WEAR, ENGLAND
[16] KAROLINSKA INST, HUDDINGE, SWEDEN
[17] UNIV OSLO, NATL HOSP, OSLO, NORWAY
[18] INST CHILD HLTH, LONDON, ENGLAND
[19] SHEFFIELD CHILDRENS HOSP, SHEFFIELD S10 2TH, S YORKSHIRE, ENGLAND
[20] UNIV HELSINKI, CHILDRENS HOSP, HELSINKI, FINLAND
[21] UNIV LEIDEN HOSP, NL-2300 RC LEIDEN, NETHERLANDS
[22] UNIV HACETTEPE, CHILDRENS HOSP, TR-06100 ANKARA, TURKEY
[23] GLAXO WELLCOME INC, GENEVA, SWITZERLAND
[24] UNIV BRESCIA, BRESCIA, ITALY
来源
JOURNAL OF PEDIATRICS | 1997年 / 131卷 / 01期
关键词
D O I
10.1016/S0022-3476(97)70123-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report the clinical and immunologic features and outcome in 56 patients with X-linked hyper-IgM syndrome, a disorder caused by mutations in the CD40 ligand gene. Upper and lower respiratory tract infections (the latter frequently caused by Pneumocystis carinii), chronic diarrhea, and liver involvement (both often associated with Cryptosporidium infection) were common. Many patients had chronic neutropenia associated with oral and rectal ulcers. The marked prevalence of infections caused by intracellular pathogens suggests some degree of impairment of cell-mediated immunity. Although lymphocyte counts and in vitro proliferation to mitogens were normal, a defective in vitro proliferative response to antigens was observed in some patients, and additional defects of cell-mediated immunity may be presumed on the basis of current knowledge of CD40-ligand function. All patients received regular infusions of immunoglobulins. Four patients underwent liver transplantation, because of sclerosing cholangitis, which relapsed in three. Three patients underwent bone marrow transplantation. Thirteen patients (23%) died of infection and/or liver disease. X-linked hyper-IgM syndrome, once considered a clinical variant of hypogammaglobulinemia, is a severe immunodeficiency with significant cellular involvement and a high mortality rate.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [41] CARRIER DETECTION IN X-LINKED HYPER-IGM SYNDROME (GP39 DEFICIENCY)
    WU, LH
    HOLLENBAUGH, D
    NONOYAMA, S
    HILL, HR
    ARUFFO, A
    OCHS, HD
    CLINICAL RESEARCH, 1994, 42 (01): : A9 - A9
  • [42] CD40 LIGAND AND ITS ROLE IN X-LINKED HYPER-IGM SYNDROME
    CALLARD, RE
    ARMITAGE, RJ
    FANSLOW, WC
    SPRIGGS, MK
    IMMUNOLOGY TODAY, 1993, 14 (11): : 559 - 564
  • [43] X-linked hyper-IgM syndrome associated with a rapid course of progressive multifocal leukoencephalopathy
    Illes, Z.
    Aschermann, Z.
    Gomori, E.
    Kovacs, G. G.
    Simon, G.
    Pal, E.
    Komoly, S.
    Marodi, L.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : CXXXI - CXXXI
  • [44] A new mutation affecting the tnfh domain in a patient with X-linked hyper-igm syndrome
    Cunha, J. M.
    Vasconcelos, D. M.
    Oliveira, J. B.
    Santos, A. R.
    Wakim, V. L.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 179 - 180
  • [45] Invasive Adenocarcinoma of Large Intestine and Gallbladder in a Patient with X-Linked Hyper-IgM Syndrome
    Tantou, S.
    Stylianidis, G.
    Argyrakos, T.
    Tzanoudaki, M.
    Makatsoris, T.
    Liatsis, M.
    Kanariou, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S472 - S473
  • [46] Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome
    Ameratunga, R
    Lederman, HM
    Sullivan, KE
    Ochs, HD
    Seyama, K
    French, JK
    Prestidge, R
    Marbrook, J
    Fanslow, WC
    Winkelstein, JA
    JOURNAL OF PEDIATRICS, 1997, 131 (01): : 147 - 150
  • [47] Autoimmune retinopathy with RPE hypersensitivity and 'negative ERG' in X-linked hyper-IgM syndrome
    Schuster, A
    Apfelstedt-Sylla, E
    Pusch, CM
    Zrenner, E
    Thirkill, CE
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (2-3) : 235 - 243
  • [48] Cutaneous sarcoid-like granulomas in a patient with X-linked hyper-IgM syndrome
    Gallerani, I
    Innocenti, DD
    Coronella, G
    Berti, S
    Amato, L
    Moretti, S
    Fabbri, P
    PEDIATRIC DERMATOLOGY, 2004, 21 (01) : 39 - 43
  • [49] Patient Specific Targeted Gene Therapy In The Treatment Of X-Linked Hyper-IgM Syndrome
    Kuo, Caroline Y.
    Joglekar, Alok
    Kohn, Donald B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB162 - AB162
  • [50] CLINICAL AND MOLECULAR FEATURES OF X-LINKED IMMUNODEFICIENCY WITH HYPER-IgM: A EUROPEAN SURVAY 5
    F Candotti
    J Levy
    S Giliani
    A G Ugazio
    L D Notarangelo
    Pediatric Research, 1997, 41 (5) : 729 - 729